*Alkem Laboratories Ltd.* | *CMP* Rs. 3011 | *M Cap* Rs. 36012 Cr | *52 W H/L* 3152/2222
(Nirmal Bang Retail Research)
*Result is below expectations*
Revenue from Operations came at Rs. 2192.2 Cr (-5.4% QoQ, 7% YoY) vs expectation of Rs. 2221.8 Cr, QoQ Rs. 2318.1 Cr, YoY Rs. 2049 Cr
EBIDTA came at Rs. 291.1 Cr (-45% QoQ, -3.9% YoY) vs expectation of Rs. 396.1 Cr, QoQ Rs. 529.1 Cr, YoY Rs. 303 Cr
EBITDA Margin came at 13.3% vs expectation of 17.8%, QoQ 22.8%, YoY 14.8%
Adj. PAT came at Rs. 249.2 Cr vs expectation of Rs. 285.3 Cr, QoQ Rs. 451 Cr, YoY Rs. 188.8 Cr
Quarter EPS is Rs. 20.8
Share is trading at P/E of 22.6x FY22E EPS
(Nirmal Bang Retail Research)
*Result is below expectations*
Revenue from Operations came at Rs. 2192.2 Cr (-5.4% QoQ, 7% YoY) vs expectation of Rs. 2221.8 Cr, QoQ Rs. 2318.1 Cr, YoY Rs. 2049 Cr
EBIDTA came at Rs. 291.1 Cr (-45% QoQ, -3.9% YoY) vs expectation of Rs. 396.1 Cr, QoQ Rs. 529.1 Cr, YoY Rs. 303 Cr
EBITDA Margin came at 13.3% vs expectation of 17.8%, QoQ 22.8%, YoY 14.8%
Adj. PAT came at Rs. 249.2 Cr vs expectation of Rs. 285.3 Cr, QoQ Rs. 451 Cr, YoY Rs. 188.8 Cr
Quarter EPS is Rs. 20.8
Share is trading at P/E of 22.6x FY22E EPS
*Emami Ltd.* | *CMP* Rs. 508 | *M Cap* Rs. 22581 Cr | *52 W H/L* 547/184
(Nirmal Bang Retail Research)
*Result below expectation*
Revenue from Operations came at Rs. 730.8 Cr (-21.7% QoQ, 37.2% YoY) vs expectation of Rs. 705.2 Cr, QoQ Rs. 933.6 Cr, YoY Rs. 532.7 Cr
EBIDTA came at Rs. 162.8 Cr (-52.1% QoQ, 65.2% YoY) vs expectation of Rs. 191.6 Cr, QoQ Rs. 340.2 Cr, YoY Rs. 98.5 Cr
EBITDA Margin came at 22.3% vs expectation of 27.2%, QoQ 36.4%, YoY 18.5%
Adj. PAT came at Rs. 87.7 Cr vs expectation of Rs. 107.8 Cr, QoQ Rs. 209 Cr, YoY Rs. 30.8 Cr
Quarter EPS is Rs. 2
Share is trading at P/E of 33.9x FY22E EPS
(Nirmal Bang Retail Research)
*Result below expectation*
Revenue from Operations came at Rs. 730.8 Cr (-21.7% QoQ, 37.2% YoY) vs expectation of Rs. 705.2 Cr, QoQ Rs. 933.6 Cr, YoY Rs. 532.7 Cr
EBIDTA came at Rs. 162.8 Cr (-52.1% QoQ, 65.2% YoY) vs expectation of Rs. 191.6 Cr, QoQ Rs. 340.2 Cr, YoY Rs. 98.5 Cr
EBITDA Margin came at 22.3% vs expectation of 27.2%, QoQ 36.4%, YoY 18.5%
Adj. PAT came at Rs. 87.7 Cr vs expectation of Rs. 107.8 Cr, QoQ Rs. 209 Cr, YoY Rs. 30.8 Cr
Quarter EPS is Rs. 2
Share is trading at P/E of 33.9x FY22E EPS
SUBEX: CO UNIT SUBEX INC RECEIVED WAIVER FOR AN AMOUNT OF US$ 799,167 ALONG WITH INTEREST OF US$ 8,302.46 RECEIVED AS BUSINESS LOAN UNDER PAYCHECK PROTECTION PROGRAM FROM THE UNITED STATES FEDERAL GOVERNMENT
*Vardhman Textiles Ltd.* | *CMP* Rs. 1356 | *M Cap* Rs. 7811 Cr | *52 W H/L* 1375/620
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 1947.1 Cr (11.3% QoQ, 22% YoY) vs QoQ Rs. 1750.1 Cr, YoY Rs. 1595.8 Cr
EBIDTA came at Rs. 405.8 Cr (46.6% QoQ, 80.2% YoY) vs QoQ Rs. 276.7 Cr, YoY Rs. 225.1 Cr
EBITDA Margin came at 20.8% vs QoQ 15.8%, YoY 14.1%
Adj. PAT came at Rs. 243.5 Cr vs QoQ Rs. 170.5 Cr, YoY Rs. 145.7 Cr
Quarter EPS is Rs. 42.3
Share is trading at P/E of 9.8x FY22E EPS
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 1947.1 Cr (11.3% QoQ, 22% YoY) vs QoQ Rs. 1750.1 Cr, YoY Rs. 1595.8 Cr
EBIDTA came at Rs. 405.8 Cr (46.6% QoQ, 80.2% YoY) vs QoQ Rs. 276.7 Cr, YoY Rs. 225.1 Cr
EBITDA Margin came at 20.8% vs QoQ 15.8%, YoY 14.1%
Adj. PAT came at Rs. 243.5 Cr vs QoQ Rs. 170.5 Cr, YoY Rs. 145.7 Cr
Quarter EPS is Rs. 42.3
Share is trading at P/E of 9.8x FY22E EPS
*Valiant Organics Ltd.* | *CMP* Rs. 1640 | *M Cap* Rs. 4461 Cr | *52 W H/L* 1991/626
(Nirmal Bang Retail Research)
*Result is ok*
Revenue from Operations came at Rs. 234 Cr (13.3% QoQ, 45.7% YoY) vs QoQ Rs. 206.6 Cr, YoY Rs. 160.6 Cr
EBIDTA came at Rs. 58.4 Cr (13.3% QoQ, 54.4% YoY) vs QoQ Rs. 51.5 Cr, YoY Rs. 37.8 Cr
EBITDA Margin came at 24.9% vs QoQ 24.9%, YoY 23.5%
Adj. PAT came at Rs. 27.6 Cr vs QoQ Rs. 31.6 Cr, YoY Rs. 21.9 Cr
Quarter EPS is Rs. 10.1
Share is trading at P/E of 49.6x TTM EPS
(Nirmal Bang Retail Research)
*Result is ok*
Revenue from Operations came at Rs. 234 Cr (13.3% QoQ, 45.7% YoY) vs QoQ Rs. 206.6 Cr, YoY Rs. 160.6 Cr
EBIDTA came at Rs. 58.4 Cr (13.3% QoQ, 54.4% YoY) vs QoQ Rs. 51.5 Cr, YoY Rs. 37.8 Cr
EBITDA Margin came at 24.9% vs QoQ 24.9%, YoY 23.5%
Adj. PAT came at Rs. 27.6 Cr vs QoQ Rs. 31.6 Cr, YoY Rs. 21.9 Cr
Quarter EPS is Rs. 10.1
Share is trading at P/E of 49.6x TTM EPS
*TTK Prestige Ltd.* | *CMP* Rs. 7700 | *M Cap* Rs. 10703 Cr | *52 W H/L* 8080/4610
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 598 Cr (-17.6% QoQ, 43% YoY) vs QoQ Rs. 725.6 Cr, YoY Rs. 418.2 Cr
EBIDTA came at Rs. 107.6 Cr (-12.6% QoQ, 190.9% YoY) vs QoQ Rs. 123.1 Cr, YoY Rs. 37 Cr
EBITDA Margin came at 18% vs QoQ 17%, YoY 8.8%
Adj. PAT came at Rs. 73.5 Cr vs QoQ Rs. 83.8 Cr, YoY Rs. 20.3 Cr
Quarter EPS is Rs. 52.8
Share is trading at P/E of 39.3x FY22E EPS
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 598 Cr (-17.6% QoQ, 43% YoY) vs QoQ Rs. 725.6 Cr, YoY Rs. 418.2 Cr
EBIDTA came at Rs. 107.6 Cr (-12.6% QoQ, 190.9% YoY) vs QoQ Rs. 123.1 Cr, YoY Rs. 37 Cr
EBITDA Margin came at 18% vs QoQ 17%, YoY 8.8%
Adj. PAT came at Rs. 73.5 Cr vs QoQ Rs. 83.8 Cr, YoY Rs. 20.3 Cr
Quarter EPS is Rs. 52.8
Share is trading at P/E of 39.3x FY22E EPS
*Lincoln Pharmaceuticals Ltd.* | *CMP* Rs. 323 | *M Cap* Rs. 646 Cr | *52 W H/L* 338/150
(Nirmal Bang Retail Research)
*Result ok*
Revenue from Operations came at Rs. 79.6 Cr (-30.6% QoQ, 1.4% YoY) vs QoQ Rs. 114.7 Cr, YoY Rs. 78.5 Cr
EBIDTA came at Rs. 15.2 Cr (-23.8% QoQ, 76.9% YoY) vs QoQ Rs. 20 Cr, YoY Rs. 8.6 Cr
EBITDA Margin came at 19.2% vs QoQ 17.4%, YoY 11%
Adj. PAT came at Rs. 12.6 Cr vs QoQ Rs. 13.5 Cr, YoY Rs. 8.9 Cr
Quarter EPS is Rs. 6.3
Share is trading at P/E of 10.4x TTM EPS
(Nirmal Bang Retail Research)
*Result ok*
Revenue from Operations came at Rs. 79.6 Cr (-30.6% QoQ, 1.4% YoY) vs QoQ Rs. 114.7 Cr, YoY Rs. 78.5 Cr
EBIDTA came at Rs. 15.2 Cr (-23.8% QoQ, 76.9% YoY) vs QoQ Rs. 20 Cr, YoY Rs. 8.6 Cr
EBITDA Margin came at 19.2% vs QoQ 17.4%, YoY 11%
Adj. PAT came at Rs. 12.6 Cr vs QoQ Rs. 13.5 Cr, YoY Rs. 8.9 Cr
Quarter EPS is Rs. 6.3
Share is trading at P/E of 10.4x TTM EPS
*Indoco Remedies Ltd.* | *CMP* Rs. 362 | *M Cap* Rs. 3338 Cr | *52 W H/L* 378/190
(Nirmal Bang Retail Research)
*Result inline with Expectation*
Revenue from Operations came at Rs. 305.1 Cr (-8.2% QoQ, 12.2% YoY) vs expectation of Rs. 324.8 Cr, QoQ Rs. 332.3 Cr, YoY Rs. 272 Cr
EBIDTA came at Rs. 54.7 Cr (-9.1% QoQ, 64.4% YoY) vs expectation of Rs. 54.5 Cr, QoQ Rs. 60.2 Cr, YoY Rs. 33.3 Cr
EBITDA Margin came at 17.9% vs expectation of 16.8%, QoQ 18.1%, YoY 12.2%
Adj. PAT came at Rs. 25 Cr vs expectation of Rs. 24.3 Cr, QoQ Rs. 25.4 Cr, YoY Rs. 5.4 Cr
Quarter EPS is Rs. 2.7
Share is trading at P/E of 35.9x TTM EPS
(Nirmal Bang Retail Research)
*Result inline with Expectation*
Revenue from Operations came at Rs. 305.1 Cr (-8.2% QoQ, 12.2% YoY) vs expectation of Rs. 324.8 Cr, QoQ Rs. 332.3 Cr, YoY Rs. 272 Cr
EBIDTA came at Rs. 54.7 Cr (-9.1% QoQ, 64.4% YoY) vs expectation of Rs. 54.5 Cr, QoQ Rs. 60.2 Cr, YoY Rs. 33.3 Cr
EBITDA Margin came at 17.9% vs expectation of 16.8%, QoQ 18.1%, YoY 12.2%
Adj. PAT came at Rs. 25 Cr vs expectation of Rs. 24.3 Cr, QoQ Rs. 25.4 Cr, YoY Rs. 5.4 Cr
Quarter EPS is Rs. 2.7
Share is trading at P/E of 35.9x TTM EPS
Dear All,
Nirmal Bang is inviting you to a Zoom webinar.
When: May 26, 2021 08:45 AM India
Topic: Morning Market Update
Register in advance for this webinar:
https://us02web.zoom.us/webinar/register/WN_3F95E3NlTheejWyvsJehdA
After registering, you will receive a confirmation email containing information about joining the webinar.
Nirmal Bang is inviting you to a Zoom webinar.
When: May 26, 2021 08:45 AM India
Topic: Morning Market Update
Register in advance for this webinar:
https://us02web.zoom.us/webinar/register/WN_3F95E3NlTheejWyvsJehdA
After registering, you will receive a confirmation email containing information about joining the webinar.
Zoom Video
Welcome! You are invited to join a webinar: Morning Market Update. After registering, you will receive a confirmation email about…